T1	Intervention 224 293	dazmegrel was orally administered to greyhound dogs wearing leg casts
T2	Intervention 854 931	pidermal exposure to bioelastic thromboxane synthetase inhibitor (TSI) matrix
T3	Intervention 975 978	TSI
T4	Intervention 1075 1177	dazmegrel in the skin layers (epidermis, dermis and subcutaneous layers) on 1, 7 and 14-day exposures.
